that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in
academic and community practices. The registry will enroll newly-diagnosed patients with
PTCL treated with a variety of regimens. The COMPLETE registry is designed to better
understand PTCL patient characteristics, treatments, and outcomes to help design and
understand future clinical trials.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.